The Veterinary Medicine Market can be segmented according to product type, animal type, route of administration, distribution channel, and geographic region.

By product type, the market includes drugs and vaccines. Drugs held the largest share in 2025, accounting for approximately 52.5% of market revenue. Vaccines are expected to experience strong growth as preventive healthcare and antimicrobial stewardship become increasingly important.

By animal type, the market is divided into domesticated and companion animals. Companion animals accounted for approximately 51.5% of spending in 2025, supported by rising pet ownership and increasing expenditure on advanced pet healthcare. Livestock treatments are also expected to expand as commercial poultry, swine, cattle, and aquaculture operations strengthen disease-prevention programs.

By route of administration, products are delivered through oral and parenteral routes, with injectable vaccines and biologics supporting demand for parenteral administration.

Distribution channels include veterinary hospitals and clinics, retail stores, and online pharmacies. The expansion of online pharmacies and telehealth services is improving access to veterinary medicines.

Regionally, North America accounted for the largest share in 2025, followed by Europe, while Asia-Pacific is expected to achieve the fastest growth through 2035.

This diverse segmentation highlights opportunities across both companion animal healthcare and livestock veterinary applications.